nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A43—Dexamethasone—psoriasis	0.125	0.156	CbGbCtD
Praziquantel—CYP3A5—Beclomethasone—psoriasis	0.069	0.086	CbGbCtD
Praziquantel—CYP1A2—Clobetasol propionate—psoriasis	0.0678	0.0845	CbGbCtD
Praziquantel—CYP1A2—Methoxsalen—psoriasis	0.0356	0.0444	CbGbCtD
Praziquantel—CYP2D6—Hydroxyurea—psoriasis	0.0321	0.04	CbGbCtD
Praziquantel—CYP3A7—Hydrocortisone—psoriasis	0.0294	0.0366	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0294	0.0366	CbGbCtD
Praziquantel—CYP3A7—Cyclosporine—psoriasis	0.0278	0.0346	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0278	0.0346	CbGbCtD
Praziquantel—CYP3A5—Mycophenolate mofetil—psoriasis	0.0275	0.0343	CbGbCtD
Praziquantel—CYP2C19—Cholecalciferol—psoriasis	0.0256	0.0319	CbGbCtD
Praziquantel—CYP3A4—Calcitriol—psoriasis	0.024	0.0299	CbGbCtD
Praziquantel—CYP3A5—Hydrocortisone—psoriasis	0.022	0.0275	CbGbCtD
Praziquantel—CYP3A5—Cyclosporine—psoriasis	0.0208	0.026	CbGbCtD
Praziquantel—CYP2D6—Cholecalciferol—psoriasis	0.0194	0.0242	CbGbCtD
Praziquantel—CYP3A4—Methoxsalen—psoriasis	0.0187	0.0233	CbGbCtD
Praziquantel—CYP3A7—Dexamethasone—psoriasis	0.0183	0.0228	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0183	0.0228	CbGbCtD
Praziquantel—CYP2C19—Prednisone—psoriasis	0.0177	0.0221	CbGbCtD
Praziquantel—CYP2C19—Cyclosporine—psoriasis	0.0168	0.0209	CbGbCtD
Praziquantel—CYP3A5—Dexamethasone—psoriasis	0.0137	0.0171	CbGbCtD
Praziquantel—CYP2D6—Cyclosporine—psoriasis	0.0128	0.0159	CbGbCtD
Praziquantel—CYP3A4—Cholecalciferol—psoriasis	0.0124	0.0154	CbGbCtD
Praziquantel—CYP2C19—Dexamethasone—psoriasis	0.0111	0.0138	CbGbCtD
Praziquantel—CYP3A4—Mycophenolate mofetil—psoriasis	0.0107	0.0134	CbGbCtD
Praziquantel—CYP3A4—Triamcinolone—psoriasis	0.0107	0.0134	CbGbCtD
Praziquantel—CYP3A4—Betamethasone—psoriasis	0.00919	0.0115	CbGbCtD
Praziquantel—CYP3A4—Prednisolone—psoriasis	0.00907	0.0113	CbGbCtD
Praziquantel—CYP3A4—Hydrocortisone—psoriasis	0.0086	0.0107	CbGbCtD
Praziquantel—CYP3A4—Prednisone—psoriasis	0.00856	0.0107	CbGbCtD
Praziquantel—CYP3A43—Miscellaneous substrates—CYP2S1—psoriasis	0.00849	0.159	CbGpPWpGaD
Praziquantel—CYP2D6—Dexamethasone—psoriasis	0.00841	0.0105	CbGbCtD
Praziquantel—CYP3A4—Cyclosporine—psoriasis	0.00812	0.0101	CbGbCtD
Praziquantel—CYP3A43—Xenobiotics—CYP2S1—psoriasis	0.00564	0.106	CbGpPWpGaD
Praziquantel—CYP3A4—Dexamethasone—psoriasis	0.00535	0.00667	CbGbCtD
Praziquantel—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00234	0.0439	CbGpPWpGaD
Praziquantel—CYP3A43—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00231	0.0433	CbGpPWpGaD
Praziquantel—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00227	0.0426	CbGpPWpGaD
Praziquantel—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00205	0.0384	CbGpPWpGaD
Praziquantel—CYP3A43—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0019	0.0356	CbGpPWpGaD
Praziquantel—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00188	0.0353	CbGpPWpGaD
Praziquantel—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00176	0.0329	CbGpPWpGaD
Praziquantel—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00164	0.0308	CbGpPWpGaD
Praziquantel—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00127	0.0238	CbGpPWpGaD
Praziquantel—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.00117	0.0219	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—CYP2S1—psoriasis	0.00101	0.0189	CbGpPWpGaD
Praziquantel—CYP3A43—Metapathway biotransformation—CYP2S1—psoriasis	0.000995	0.0186	CbGpPWpGaD
Praziquantel—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.00099	0.0185	CbGpPWpGaD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000944	0.0177	CbGpPWpGaD
Praziquantel—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000931	0.0175	CbGpPWpGaD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000765	0.0143	CbGpPWpGaD
Praziquantel—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000764	0.0143	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000682	0.0128	CbGpPWpGaD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000673	0.0126	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000553	0.0104	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000527	0.00988	CbGpPWpGaD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000521	0.00975	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000485	0.00909	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000479	0.00897	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000428	0.00801	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000411	0.0077	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000406	0.00761	CbGpPWpGaD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000406	0.0076	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000401	0.00751	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000393	0.00737	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000333	0.00624	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000317	0.00594	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000313	0.00586	CbGpPWpGaD
Praziquantel—Discomfort—Cyclosporine—psoriasis	0.000311	0.00215	CcSEcCtD
Praziquantel—Feeling abnormal—Mycophenolic acid—psoriasis	0.000307	0.00213	CcSEcCtD
Praziquantel—Myalgia—Mycophenolate mofetil—psoriasis	0.000307	0.00212	CcSEcCtD
Praziquantel—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000305	0.00211	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000305	0.00211	CcSEcCtD
Praziquantel—Ill-defined disorder—Hydrocortisone—psoriasis	0.000305	0.00211	CcSEcCtD
Praziquantel—Diarrhoea—Hydroxyurea—psoriasis	0.000305	0.00211	CcSEcCtD
Praziquantel—Malaise—Prednisolone—psoriasis	0.000303	0.0021	CcSEcCtD
Praziquantel—Discomfort—Mycophenolate mofetil—psoriasis	0.000303	0.0021	CcSEcCtD
Praziquantel—Vertigo—Prednisolone—psoriasis	0.000302	0.00209	CcSEcCtD
Praziquantel—Malaise—Hydrocortisone—psoriasis	0.000296	0.00205	CcSEcCtD
Praziquantel—Nervous system disorder—Cyclosporine—psoriasis	0.000296	0.00205	CcSEcCtD
Praziquantel—Vertigo—Hydrocortisone—psoriasis	0.000295	0.00204	CcSEcCtD
Praziquantel—Abdominal pain—Mycophenolic acid—psoriasis	0.000295	0.00204	CcSEcCtD
Praziquantel—Body temperature increased—Mycophenolic acid—psoriasis	0.000295	0.00204	CcSEcCtD
Praziquantel—Dizziness—Hydroxyurea—psoriasis	0.000295	0.00204	CcSEcCtD
Praziquantel—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000294	0.0055	CbGpPWpGaD
Praziquantel—Skin disorder—Cyclosporine—psoriasis	0.000293	0.00203	CcSEcCtD
Praziquantel—Convulsion—Prednisolone—psoriasis	0.000292	0.00202	CcSEcCtD
Praziquantel—Eosinophilia—Methotrexate—psoriasis	0.00029	0.00201	CcSEcCtD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.00029	0.00543	CbGpPWpGaD
Praziquantel—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000289	0.002	CcSEcCtD
Praziquantel—Arrhythmia—Betamethasone—psoriasis	0.000288	0.00199	CcSEcCtD
Praziquantel—Arrhythmia—Dexamethasone—psoriasis	0.000288	0.00199	CcSEcCtD
Praziquantel—Anorexia—Cyclosporine—psoriasis	0.000288	0.00199	CcSEcCtD
Praziquantel—Ill-defined disorder—Triamcinolone—psoriasis	0.000287	0.00199	CcSEcCtD
Praziquantel—Skin disorder—Mycophenolate mofetil—psoriasis	0.000286	0.00198	CcSEcCtD
Praziquantel—Bradycardia—Prednisone—psoriasis	0.000286	0.00198	CcSEcCtD
Praziquantel—Convulsion—Hydrocortisone—psoriasis	0.000285	0.00197	CcSEcCtD
Praziquantel—Vomiting—Hydroxyurea—psoriasis	0.000283	0.00196	CcSEcCtD
Praziquantel—Discomfort—Prednisolone—psoriasis	0.000283	0.00196	CcSEcCtD
Praziquantel—Abdominal discomfort—Methotrexate—psoriasis	0.000281	0.00194	CcSEcCtD
Praziquantel—Rash—Hydroxyurea—psoriasis	0.000281	0.00194	CcSEcCtD
Praziquantel—Anorexia—Mycophenolate mofetil—psoriasis	0.000281	0.00194	CcSEcCtD
Praziquantel—Dermatitis—Hydroxyurea—psoriasis	0.000281	0.00194	CcSEcCtD
Praziquantel—Myalgia—Hydrocortisone—psoriasis	0.00028	0.00193	CcSEcCtD
Praziquantel—Malaise—Triamcinolone—psoriasis	0.000279	0.00193	CcSEcCtD
Praziquantel—Headache—Hydroxyurea—psoriasis	0.000279	0.00193	CcSEcCtD
Praziquantel—Vertigo—Triamcinolone—psoriasis	0.000278	0.00192	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000278	0.00192	CcSEcCtD
Praziquantel—Discomfort—Hydrocortisone—psoriasis	0.000276	0.00191	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000275	0.0019	CcSEcCtD
Praziquantel—Somnolence—Cyclosporine—psoriasis	0.000268	0.00186	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000268	0.00185	CcSEcCtD
Praziquantel—Convulsion—Triamcinolone—psoriasis	0.000268	0.00185	CcSEcCtD
Praziquantel—Asthenia—Mycophenolic acid—psoriasis	0.000268	0.00185	CcSEcCtD
Praziquantel—Nausea—Hydroxyurea—psoriasis	0.000265	0.00183	CcSEcCtD
Praziquantel—Pruritus—Mycophenolic acid—psoriasis	0.000264	0.00182	CcSEcCtD
Praziquantel—Myalgia—Triamcinolone—psoriasis	0.000263	0.00182	CcSEcCtD
Praziquantel—Nervous system disorder—Hydrocortisone—psoriasis	0.000263	0.00182	CcSEcCtD
Praziquantel—Decreased appetite—Cyclosporine—psoriasis	0.000262	0.00181	CcSEcCtD
Praziquantel—Somnolence—Mycophenolate mofetil—psoriasis	0.000262	0.00181	CcSEcCtD
Praziquantel—Drowsiness—Methotrexate—psoriasis	0.000261	0.00181	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000261	0.0018	CcSEcCtD
Praziquantel—Skin disorder—Hydrocortisone—psoriasis	0.000261	0.0018	CcSEcCtD
Praziquantel—Ill-defined disorder—Dexamethasone—psoriasis	0.00026	0.0018	CcSEcCtD
Praziquantel—Ill-defined disorder—Betamethasone—psoriasis	0.00026	0.0018	CcSEcCtD
Praziquantel—Discomfort—Triamcinolone—psoriasis	0.00026	0.0018	CcSEcCtD
Praziquantel—Fatigue—Cyclosporine—psoriasis	0.00026	0.0018	CcSEcCtD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000257	0.00482	CbGpPWpGaD
Praziquantel—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000256	0.00177	CcSEcCtD
Praziquantel—Anorexia—Hydrocortisone—psoriasis	0.000256	0.00177	CcSEcCtD
Praziquantel—Diarrhoea—Mycophenolic acid—psoriasis	0.000255	0.00176	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000254	0.00176	CcSEcCtD
Praziquantel—Immune system disorder—Prednisone—psoriasis	0.000254	0.00175	CcSEcCtD
Praziquantel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000254	0.00475	CbGpPWpGaD
Praziquantel—Malaise—Betamethasone—psoriasis	0.000253	0.00175	CcSEcCtD
Praziquantel—Malaise—Dexamethasone—psoriasis	0.000253	0.00175	CcSEcCtD
Praziquantel—Vertigo—Dexamethasone—psoriasis	0.000252	0.00174	CcSEcCtD
Praziquantel—Vertigo—Betamethasone—psoriasis	0.000252	0.00174	CcSEcCtD
Praziquantel—Arrhythmia—Prednisone—psoriasis	0.000251	0.00173	CcSEcCtD
Praziquantel—Feeling abnormal—Cyclosporine—psoriasis	0.000249	0.00172	CcSEcCtD
Praziquantel—Gastrointestinal pain—Cyclosporine—psoriasis	0.000247	0.00171	CcSEcCtD
Praziquantel—Dizziness—Mycophenolic acid—psoriasis	0.000247	0.00171	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000244	0.00169	CcSEcCtD
Praziquantel—Convulsion—Dexamethasone—psoriasis	0.000243	0.00168	CcSEcCtD
Praziquantel—Convulsion—Betamethasone—psoriasis	0.000243	0.00168	CcSEcCtD
Praziquantel—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000243	0.00168	CcSEcCtD
Praziquantel—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000241	0.00166	CcSEcCtD
Praziquantel—Urticaria—Cyclosporine—psoriasis	0.00024	0.00166	CcSEcCtD
Praziquantel—Myalgia—Dexamethasone—psoriasis	0.000239	0.00165	CcSEcCtD
Praziquantel—Myalgia—Betamethasone—psoriasis	0.000239	0.00165	CcSEcCtD
Praziquantel—Abdominal pain—Cyclosporine—psoriasis	0.000239	0.00165	CcSEcCtD
Praziquantel—Body temperature increased—Cyclosporine—psoriasis	0.000239	0.00165	CcSEcCtD
Praziquantel—Vomiting—Mycophenolic acid—psoriasis	0.000237	0.00164	CcSEcCtD
Praziquantel—Discomfort—Betamethasone—psoriasis	0.000236	0.00163	CcSEcCtD
Praziquantel—Discomfort—Dexamethasone—psoriasis	0.000236	0.00163	CcSEcCtD
Praziquantel—Rash—Mycophenolic acid—psoriasis	0.000235	0.00163	CcSEcCtD
Praziquantel—Dermatitis—Mycophenolic acid—psoriasis	0.000235	0.00162	CcSEcCtD
Praziquantel—Urticaria—Mycophenolate mofetil—psoriasis	0.000234	0.00162	CcSEcCtD
Praziquantel—Headache—Mycophenolic acid—psoriasis	0.000234	0.00162	CcSEcCtD
Praziquantel—Decreased appetite—Hydrocortisone—psoriasis	0.000233	0.00161	CcSEcCtD
Praziquantel—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000233	0.00161	CcSEcCtD
Praziquantel—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000233	0.00161	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000232	0.0016	CcSEcCtD
Praziquantel—Fatigue—Hydrocortisone—psoriasis	0.000231	0.0016	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00023	0.00159	CcSEcCtD
Praziquantel—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000227	0.00426	CbGpPWpGaD
Praziquantel—Ill-defined disorder—Prednisone—psoriasis	0.000227	0.00157	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisolone—psoriasis	0.000226	0.00156	CcSEcCtD
Praziquantel—Nervous system disorder—Dexamethasone—psoriasis	0.000225	0.00155	CcSEcCtD
Praziquantel—Nervous system disorder—Betamethasone—psoriasis	0.000225	0.00155	CcSEcCtD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000224	0.0042	CbGpPWpGaD
Praziquantel—Hypersensitivity—Cyclosporine—psoriasis	0.000222	0.00154	CcSEcCtD
Praziquantel—Nausea—Mycophenolic acid—psoriasis	0.000222	0.00153	CcSEcCtD
Praziquantel—Feeling abnormal—Hydrocortisone—psoriasis	0.000221	0.00153	CcSEcCtD
Praziquantel—Malaise—Prednisone—psoriasis	0.00022	0.00152	CcSEcCtD
Praziquantel—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.00022	0.00413	CbGpPWpGaD
Praziquantel—Vertigo—Prednisone—psoriasis	0.00022	0.00152	CcSEcCtD
Praziquantel—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000219	0.00152	CcSEcCtD
Praziquantel—Anorexia—Betamethasone—psoriasis	0.000218	0.00151	CcSEcCtD
Praziquantel—Anorexia—Dexamethasone—psoriasis	0.000218	0.00151	CcSEcCtD
Praziquantel—Urticaria—Prednisolone—psoriasis	0.000218	0.00151	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—psoriasis	0.000218	0.00151	CcSEcCtD
Praziquantel—Fatigue—Triamcinolone—psoriasis	0.000218	0.00151	CcSEcCtD
Praziquantel—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000217	0.0015	CcSEcCtD
Praziquantel—Asthenia—Cyclosporine—psoriasis	0.000217	0.0015	CcSEcCtD
Praziquantel—Pruritus—Cyclosporine—psoriasis	0.000214	0.00148	CcSEcCtD
Praziquantel—Urticaria—Hydrocortisone—psoriasis	0.000213	0.00147	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—psoriasis	0.000212	0.00147	CcSEcCtD
Praziquantel—Abdominal pain—Hydrocortisone—psoriasis	0.000212	0.00147	CcSEcCtD
Praziquantel—Body temperature increased—Hydrocortisone—psoriasis	0.000212	0.00147	CcSEcCtD
Praziquantel—Convulsion—Prednisone—psoriasis	0.000212	0.00146	CcSEcCtD
Praziquantel—Asthenia—Mycophenolate mofetil—psoriasis	0.000211	0.00146	CcSEcCtD
Praziquantel—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000209	0.00391	CbGpPWpGaD
Praziquantel—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000209	0.00144	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000209	0.00144	CcSEcCtD
Praziquantel—Pruritus—Mycophenolate mofetil—psoriasis	0.000208	0.00144	CcSEcCtD
Praziquantel—Myalgia—Prednisone—psoriasis	0.000208	0.00144	CcSEcCtD
Praziquantel—Feeling abnormal—Triamcinolone—psoriasis	0.000208	0.00144	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000207	0.00143	CcSEcCtD
Praziquantel—Diarrhoea—Cyclosporine—psoriasis	0.000206	0.00143	CcSEcCtD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000206	0.00386	CbGpPWpGaD
Praziquantel—Discomfort—Prednisone—psoriasis	0.000206	0.00142	CcSEcCtD
Praziquantel—CYP3A43—Metabolism—NDUFA5—psoriasis	0.000203	0.0038	CbGpPWpGaD
Praziquantel—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000203	0.00379	CbGpPWpGaD
Praziquantel—Hypersensitivity—Prednisolone—psoriasis	0.000202	0.0014	CcSEcCtD
Praziquantel—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000201	0.00377	CbGpPWpGaD
Praziquantel—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000201	0.00139	CcSEcCtD
Praziquantel—Urticaria—Triamcinolone—psoriasis	0.000201	0.00139	CcSEcCtD
Praziquantel—Body temperature increased—Triamcinolone—psoriasis	0.0002	0.00138	CcSEcCtD
Praziquantel—Dizziness—Cyclosporine—psoriasis	0.0002	0.00138	CcSEcCtD
Praziquantel—Decreased appetite—Dexamethasone—psoriasis	0.000199	0.00138	CcSEcCtD
Praziquantel—Decreased appetite—Betamethasone—psoriasis	0.000199	0.00138	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Betamethasone—psoriasis	0.000198	0.00137	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000198	0.00137	CcSEcCtD
Praziquantel—Hypersensitivity—Hydrocortisone—psoriasis	0.000198	0.00137	CcSEcCtD
Praziquantel—Fatigue—Dexamethasone—psoriasis	0.000198	0.00137	CcSEcCtD
Praziquantel—Fatigue—Betamethasone—psoriasis	0.000198	0.00137	CcSEcCtD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000197	0.00369	CbGpPWpGaD
Praziquantel—Nervous system disorder—Prednisone—psoriasis	0.000196	0.00135	CcSEcCtD
Praziquantel—Dizziness—Mycophenolate mofetil—psoriasis	0.000195	0.00135	CcSEcCtD
Praziquantel—Skin disorder—Prednisone—psoriasis	0.000194	0.00134	CcSEcCtD
Praziquantel—Asthenia—Hydrocortisone—psoriasis	0.000192	0.00133	CcSEcCtD
Praziquantel—Vomiting—Cyclosporine—psoriasis	0.000192	0.00133	CcSEcCtD
Praziquantel—Rash—Cyclosporine—psoriasis	0.00019	0.00132	CcSEcCtD
Praziquantel—Anorexia—Prednisone—psoriasis	0.00019	0.00132	CcSEcCtD
Praziquantel—Dermatitis—Cyclosporine—psoriasis	0.00019	0.00131	CcSEcCtD
Praziquantel—Pruritus—Hydrocortisone—psoriasis	0.00019	0.00131	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—psoriasis	0.00019	0.00131	CcSEcCtD
Praziquantel—Headache—Cyclosporine—psoriasis	0.000189	0.00131	CcSEcCtD
Praziquantel—Feeling abnormal—Betamethasone—psoriasis	0.000189	0.00131	CcSEcCtD
Praziquantel—Feeling abnormal—Dexamethasone—psoriasis	0.000189	0.00131	CcSEcCtD
Praziquantel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000189	0.00354	CbGpPWpGaD
Praziquantel—Gastrointestinal pain—Dexamethasone—psoriasis	0.000187	0.0013	CcSEcCtD
Praziquantel—Gastrointestinal pain—Betamethasone—psoriasis	0.000187	0.0013	CcSEcCtD
Praziquantel—Vomiting—Mycophenolate mofetil—psoriasis	0.000187	0.00129	CcSEcCtD
Praziquantel—Hypersensitivity—Triamcinolone—psoriasis	0.000186	0.00129	CcSEcCtD
Praziquantel—Rash—Mycophenolate mofetil—psoriasis	0.000186	0.00128	CcSEcCtD
Praziquantel—Dermatitis—Mycophenolate mofetil—psoriasis	0.000185	0.00128	CcSEcCtD
Praziquantel—Headache—Mycophenolate mofetil—psoriasis	0.000184	0.00128	CcSEcCtD
Praziquantel—Malaise—Methotrexate—psoriasis	0.000184	0.00127	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—psoriasis	0.000184	0.00127	CcSEcCtD
Praziquantel—Diarrhoea—Hydrocortisone—psoriasis	0.000183	0.00127	CcSEcCtD
Praziquantel—Urticaria—Betamethasone—psoriasis	0.000182	0.00126	CcSEcCtD
Praziquantel—Urticaria—Dexamethasone—psoriasis	0.000182	0.00126	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Prednisone—psoriasis	0.000182	0.00126	CcSEcCtD
Praziquantel—Dizziness—Prednisolone—psoriasis	0.000182	0.00126	CcSEcCtD
Praziquantel—Asthenia—Triamcinolone—psoriasis	0.000181	0.00125	CcSEcCtD
Praziquantel—Body temperature increased—Dexamethasone—psoriasis	0.000181	0.00125	CcSEcCtD
Praziquantel—Abdominal pain—Dexamethasone—psoriasis	0.000181	0.00125	CcSEcCtD
Praziquantel—Abdominal pain—Betamethasone—psoriasis	0.000181	0.00125	CcSEcCtD
Praziquantel—Body temperature increased—Betamethasone—psoriasis	0.000181	0.00125	CcSEcCtD
Praziquantel—Nausea—Cyclosporine—psoriasis	0.000179	0.00124	CcSEcCtD
Praziquantel—Pruritus—Triamcinolone—psoriasis	0.000179	0.00124	CcSEcCtD
Praziquantel—Dizziness—Hydrocortisone—psoriasis	0.000177	0.00123	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—psoriasis	0.000177	0.00122	CcSEcCtD
Praziquantel—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000177	0.00332	CbGpPWpGaD
Praziquantel—Nausea—Mycophenolate mofetil—psoriasis	0.000175	0.00121	CcSEcCtD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000175	0.00327	CbGpPWpGaD
Praziquantel—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000174	0.00326	CbGpPWpGaD
Praziquantel—Myalgia—Methotrexate—psoriasis	0.000174	0.0012	CcSEcCtD
Praziquantel—Decreased appetite—Prednisone—psoriasis	0.000173	0.0012	CcSEcCtD
Praziquantel—Rash—Prednisolone—psoriasis	0.000173	0.0012	CcSEcCtD
Praziquantel—Dermatitis—Prednisolone—psoriasis	0.000173	0.0012	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000173	0.00119	CcSEcCtD
Praziquantel—CYP3A43—Metabolism—CYP2S1—psoriasis	0.000173	0.00323	CbGpPWpGaD
Praziquantel—Fatigue—Prednisone—psoriasis	0.000172	0.00119	CcSEcCtD
Praziquantel—Headache—Prednisolone—psoriasis	0.000172	0.00119	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—psoriasis	0.000172	0.00119	CcSEcCtD
Praziquantel—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000172	0.00321	CbGpPWpGaD
Praziquantel—Vomiting—Hydrocortisone—psoriasis	0.000171	0.00118	CcSEcCtD
Praziquantel—Rash—Hydrocortisone—psoriasis	0.000169	0.00117	CcSEcCtD
Praziquantel—Dermatitis—Hydrocortisone—psoriasis	0.000169	0.00117	CcSEcCtD
Praziquantel—Headache—Hydrocortisone—psoriasis	0.000168	0.00116	CcSEcCtD
Praziquantel—Dizziness—Triamcinolone—psoriasis	0.000167	0.00115	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisone—psoriasis	0.000164	0.00114	CcSEcCtD
Praziquantel—Asthenia—Dexamethasone—psoriasis	0.000164	0.00114	CcSEcCtD
Praziquantel—Asthenia—Betamethasone—psoriasis	0.000164	0.00114	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—psoriasis	0.000164	0.00113	CcSEcCtD
Praziquantel—Gastrointestinal pain—Prednisone—psoriasis	0.000163	0.00113	CcSEcCtD
Praziquantel—Nausea—Prednisolone—psoriasis	0.000163	0.00113	CcSEcCtD
Praziquantel—Pruritus—Betamethasone—psoriasis	0.000162	0.00112	CcSEcCtD
Praziquantel—Pruritus—Dexamethasone—psoriasis	0.000162	0.00112	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—psoriasis	0.000162	0.00112	CcSEcCtD
Praziquantel—Vomiting—Triamcinolone—psoriasis	0.000161	0.00111	CcSEcCtD
Praziquantel—Nausea—Hydrocortisone—psoriasis	0.000159	0.0011	CcSEcCtD
Praziquantel—Rash—Triamcinolone—psoriasis	0.000159	0.0011	CcSEcCtD
Praziquantel—Dermatitis—Triamcinolone—psoriasis	0.000159	0.0011	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—psoriasis	0.000159	0.0011	CcSEcCtD
Praziquantel—Urticaria—Prednisone—psoriasis	0.000159	0.0011	CcSEcCtD
Praziquantel—Headache—Triamcinolone—psoriasis	0.000158	0.00109	CcSEcCtD
Praziquantel—Body temperature increased—Prednisone—psoriasis	0.000158	0.00109	CcSEcCtD
Praziquantel—Abdominal pain—Prednisone—psoriasis	0.000158	0.00109	CcSEcCtD
Praziquantel—Diarrhoea—Dexamethasone—psoriasis	0.000157	0.00108	CcSEcCtD
Praziquantel—Diarrhoea—Betamethasone—psoriasis	0.000157	0.00108	CcSEcCtD
Praziquantel—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000153	0.00286	CbGpPWpGaD
Praziquantel—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000152	0.00105	CcSEcCtD
Praziquantel—Dizziness—Dexamethasone—psoriasis	0.000152	0.00105	CcSEcCtD
Praziquantel—Dizziness—Betamethasone—psoriasis	0.000152	0.00105	CcSEcCtD
Praziquantel—Nausea—Triamcinolone—psoriasis	0.00015	0.00104	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—psoriasis	0.000148	0.00103	CcSEcCtD
Praziquantel—Hypersensitivity—Prednisone—psoriasis	0.000147	0.00102	CcSEcCtD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000146	0.00273	CbGpPWpGaD
Praziquantel—Vomiting—Betamethasone—psoriasis	0.000146	0.00101	CcSEcCtD
Praziquantel—Vomiting—Dexamethasone—psoriasis	0.000146	0.00101	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—psoriasis	0.000145	0.001	CcSEcCtD
Praziquantel—Rash—Betamethasone—psoriasis	0.000144	0.000999	CcSEcCtD
Praziquantel—Rash—Dexamethasone—psoriasis	0.000144	0.000999	CcSEcCtD
Praziquantel—Dermatitis—Dexamethasone—psoriasis	0.000144	0.000998	CcSEcCtD
Praziquantel—Dermatitis—Betamethasone—psoriasis	0.000144	0.000998	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—psoriasis	0.000144	0.000996	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—psoriasis	0.000144	0.000994	CcSEcCtD
Praziquantel—Headache—Betamethasone—psoriasis	0.000144	0.000993	CcSEcCtD
Praziquantel—Headache—Dexamethasone—psoriasis	0.000144	0.000993	CcSEcCtD
Praziquantel—Asthenia—Prednisone—psoriasis	0.000143	0.00099	CcSEcCtD
Praziquantel—Pruritus—Prednisone—psoriasis	0.000141	0.000976	CcSEcCtD
Praziquantel—Feeling abnormal—Methotrexate—psoriasis	0.000137	0.00095	CcSEcCtD
Praziquantel—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000137	0.00256	CbGpPWpGaD
Praziquantel—Diarrhoea—Prednisone—psoriasis	0.000137	0.000944	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—psoriasis	0.000136	0.000943	CcSEcCtD
Praziquantel—Nausea—Dexamethasone—psoriasis	0.000136	0.000941	CcSEcCtD
Praziquantel—Nausea—Betamethasone—psoriasis	0.000136	0.000941	CcSEcCtD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000135	0.00252	CbGpPWpGaD
Praziquantel—Urticaria—Methotrexate—psoriasis	0.000132	0.000916	CcSEcCtD
Praziquantel—Dizziness—Prednisone—psoriasis	0.000132	0.000912	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—psoriasis	0.000132	0.000912	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—psoriasis	0.000132	0.000912	CcSEcCtD
Praziquantel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000132	0.00247	CbGpPWpGaD
Praziquantel—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000131	0.00245	CbGpPWpGaD
Praziquantel—Vomiting—Prednisone—psoriasis	0.000127	0.000877	CcSEcCtD
Praziquantel—Rash—Prednisone—psoriasis	0.000126	0.00087	CcSEcCtD
Praziquantel—Dermatitis—Prednisone—psoriasis	0.000126	0.000869	CcSEcCtD
Praziquantel—Headache—Prednisone—psoriasis	0.000125	0.000864	CcSEcCtD
Praziquantel—Hypersensitivity—Methotrexate—psoriasis	0.000123	0.00085	CcSEcCtD
Praziquantel—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.00012	0.00226	CbGpPWpGaD
Praziquantel—Asthenia—Methotrexate—psoriasis	0.00012	0.000827	CcSEcCtD
Praziquantel—Nausea—Prednisone—psoriasis	0.000119	0.00082	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—psoriasis	0.000118	0.000816	CcSEcCtD
Praziquantel—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000118	0.00221	CbGpPWpGaD
Praziquantel—Diarrhoea—Methotrexate—psoriasis	0.000114	0.000789	CcSEcCtD
Praziquantel—Dizziness—Methotrexate—psoriasis	0.00011	0.000763	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—psoriasis	0.000106	0.000733	CcSEcCtD
Praziquantel—Rash—Methotrexate—psoriasis	0.000105	0.000727	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—psoriasis	0.000105	0.000726	CcSEcCtD
Praziquantel—Headache—Methotrexate—psoriasis	0.000104	0.000722	CcSEcCtD
Praziquantel—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000102	0.00191	CbGpPWpGaD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000102	0.0019	CbGpPWpGaD
Praziquantel—Nausea—Methotrexate—psoriasis	9.91e-05	0.000685	CcSEcCtD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	8.48e-05	0.00159	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CARM1—psoriasis	8.43e-05	0.00158	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—NDUFA5—psoriasis	8.17e-05	0.00153	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	7.33e-05	0.00137	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	7.06e-05	0.00132	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP2S1—psoriasis	6.95e-05	0.0013	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.4e-05	0.0012	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NDUFA5—psoriasis	5.91e-05	0.00111	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.49e-05	0.00103	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.49e-05	0.00103	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CAT—psoriasis	5.18e-05	0.000971	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP2S1—psoriasis	5.02e-05	0.000941	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NDUFA5—psoriasis	4.57e-05	0.000856	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.26e-05	0.000798	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NDUFA5—psoriasis	4.2e-05	0.000787	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—APOE—psoriasis	4.03e-05	0.000755	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP2S1—psoriasis	3.88e-05	0.000728	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP2S1—psoriasis	3.57e-05	0.000669	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NDUFA5—psoriasis	3.56e-05	0.000667	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PPARG—psoriasis	3.51e-05	0.000657	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CARM1—psoriasis	3.39e-05	0.000636	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.32e-05	0.000622	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP2S1—psoriasis	3.03e-05	0.000567	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NDUFA5—psoriasis	2.75e-05	0.000515	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CARM1—psoriasis	2.45e-05	0.00046	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP2S1—psoriasis	2.34e-05	0.000438	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CAT—psoriasis	2.09e-05	0.000391	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.04e-05	0.000381	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CARM1—psoriasis	1.9e-05	0.000355	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.77e-05	0.000332	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CARM1—psoriasis	1.74e-05	0.000327	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—APOE—psoriasis	1.62e-05	0.000304	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.59e-05	0.000297	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CAT—psoriasis	1.51e-05	0.000283	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CARM1—psoriasis	1.48e-05	0.000277	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PPARG—psoriasis	1.41e-05	0.000265	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.38e-05	0.000259	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—APOE—psoriasis	1.17e-05	0.00022	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CAT—psoriasis	1.17e-05	0.000219	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CARM1—psoriasis	1.14e-05	0.000214	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CAT—psoriasis	1.07e-05	0.000201	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PPARG—psoriasis	1.02e-05	0.000191	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CAT—psoriasis	9.09e-06	0.00017	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—APOE—psoriasis	9.07e-06	0.00017	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—APOE—psoriasis	8.34e-06	0.000156	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PPARG—psoriasis	7.9e-06	0.000148	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PPARG—psoriasis	7.26e-06	0.000136	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—APOE—psoriasis	7.06e-06	0.000132	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CAT—psoriasis	7.02e-06	0.000131	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PPARG—psoriasis	6.15e-06	0.000115	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—APOE—psoriasis	5.45e-06	0.000102	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PPARG—psoriasis	4.75e-06	8.9e-05	CbGpPWpGaD
